← Back to Patent Explorer
US4837379A Expired / Lapsed US ⏱️ 0.0 years remaining

Fibrin-collagen tissue equivalents and methods for preparation thereof

Assignee: Organogenesis Inc
•
Filing: 1988-06-02
•
Granted: 1989-06-06
•
Expires: 2008-06-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention provides fibrin-collagen tissue equivalents and methods of making and using such tissue equivalents. The present invention also provides methods of forming multi-layer tissue equivalents having improved adherence of the layers. The present invention further provides a method for joining tears in tissue equivalents.

Inventors

  • 👤 Crispin B. Weinberg

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 22:31
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/36; A61L27/38; A61L27/14; A61L27/22; A61L27/225; A61L27/24; A61L27/50; A61L27/507; A61L27/54; A61L27/60; A61P; A61P17/00; A61P43/00; C; C07; C07K; C07K17/00; C07K17/02; C07K17/06; C12; C12N; C12N5/00; C12N5/0068; C12N5/06; C12N5/0602; C12N5/069; C12N5/0691; A61F; A61F2310/00; A61F2310/00005; A61F2310/00365; A61F2310/00377; C12N2533/00; C12N2533/50; C12N2533/54; C12N2533/56

Claims Analysis

Total Claims: 54
Claim 1
Independent Claim 17 words
A tissue equivalent comprising (i) a hydrated collagen lattice contracted by a contractile agent and (ii) fibrin.
Claim 2
Dependent Claim 17 words
A tissue equivalent comprising (i) a hydrated collagen lattice contracted by a contractile agent and (ii) fibrin.
Claim 3
Dependent Claim 14 words
The tissue equivalent of claim 1, wherein the fibrin and the collagen are cross-linked.
Claim 4
Dependent Claim 26 words
The tissue equivalent of claim 1, wherein the collagen and the fibrin are each at a concentration of from about 3 to 30 mg/cm 3 .
Claim 5
Dependent Claim 39 words
The tissue equivalent of claim 1, wherein the collagen is at a concentration of from about 10 to about 15 mg/cm 3 and the fibrin is at a concentration of from about 15 to about 25 mg/cm 3 .
Claim 6
Dependent Claim 23 words
The tissue equivalent of claim 1, wherein the contractile agent comprises a cell type which is capable of contracting a hydrated collagen lattice.
Claim 7
Dependent Claim 24 words
The tissue equivalent of claim 1, wherein the contractile agent comprises fibroblasts, smooth muscle cells, striated muscle cells, heart muscle cells or blood platelets.
Claim 8
Dependent Claim 16 words
The tissue equivalent of claim 1, wherein the lattice further comprises keratinocytes or demineralized bone powder.
Claim 9
Dependent Claim 21 words
The tissue equivalent of claim 1, wherein the tissue equivalent is a skin, bone, blood vessel, organ or gland tissue equivalent.
Claim 10
Dependent Claim 13 words
The tissue equivalent of claim 1, further comprising at least one protease inhibitor.
Claim 11
Dependent Claim 29 words
A tissue equivalent having at least two layers, wherein one or more of the layers comprises (i) a hydrated collagen lattice contracted by a contractile agent and (ii) fibrin.
Claim 12
Dependent Claim 29 words
A tissue equivalent having at least two layers, wherein one or more of the layers comprises (i) a hydrated collagen lattice contracted by a contractile agent and (ii) fibrin.
Claim 13
Independent Claim 84 words
A method of producing a tissue-equivalent, the method comprising: (a) forming a mixture comprising collagen, fibrinogen, an agent which causes the formation of fibrin from fibrinogen and at least one contractile agent under conditions to form a gel having the collagen, the fibrinogen, the agent which causes the formation of fibrin from fibrinogen and the contractile agent dispersed within said gel mixture; and (b) maintaining the gel prepared in step (a) under conditions which permit contraction of the gel to form a tissue equivalent.
Claim 14
Independent Claim 84 words
A method of producing a tissue-equivalent, the method comprising: (a) forming a mixture comprising collagen, fibrinogen, an agent which causes the formation of fibrin from fibrinogen and at least one contractile agent under conditions to form a gel having the collagen, the fibrinogen, the agent which causes the formation of fibrin from fibrinogen and the contractile agent dispersed within said gel mixture; and (b) maintaining the gel prepared in step (a) under conditions which permit contraction of the gel to form a tissue equivalent.
Claim 15
Dependent Claim 18 words
The method of claim 11, wherein the agent which causes the formation of fibrin from fibrinogen comprises thrombin.
Claim 16
Dependent Claim 26 words
The method of claim 11, wherein the mixture further comprises an agent or is exposed to an agent which causes the cross-linking of fibrin and collagen.
Claim 17
Dependent Claim 12 words
The method of claim 13, wherein the cross-linking agent is Factor XIII.
Claim 18
Dependent Claim 16 words
The method of claim 11, additionally including adding living cells into or onto the tissue equivalent.
Claim 19
Dependent Claim 24 words
The method of claim 11, wherein the collagen and the fibrinogen are each at a concentration of from about 0.3 to about 3.0 mg/ml.
Claim 20
Dependent Claim 34 words
The method of claim 11, wherein the collagen is at a concentration of from about 1.0 to 1.5 mg/ml and the fibrinogen is at a concentration of from about 1.5 to about 2.5 mg/ml.
Claim 21
Dependent Claim 11 words
A tissue equivalent formed according to the method of claim 11.
Claim 22
Dependent Claim 27 words
The tissue equivalent of claim 18, wherein the collagen and the fibrin are each at a concentration of from about 3 to about 30 mg/cm 3 .
Claim 23
Dependent Claim 39 words
The tissue equivalent of claim 18, wherein the collagen is at a concentration of from about 10 to about 15 mg/cm 3 and the fibrin is at a concentration of from about 15 to about 25 mg/cm 3 .
Claim 24
Independent Claim 84 words
A method of producing a tissue equivalent, the method comprising: (a) forming a mixture comprising collagen and at least one contractile agent under conditions to form a gel having the collagen and contractile agent dispersed therein; (b) maintaining the gel obtained in step (a) under conditions which permit contraction of the gel to form a tissue equivalent; and (c) applying fibrinogen and an agent which causes the formation of fibrin from fibrinogen to at least one surface of the tissue equivalent of step (b).
Claim 25
Independent Claim 84 words
A method of producing a tissue equivalent, the method comprising: (a) forming a mixture comprising collagen and at least one contractile agent under conditions to form a gel having the collagen and contractile agent dispersed therein; (b) maintaining the gel obtained in step (a) under conditions which permit contraction of the gel to form a tissue equivalent; and (c) applying fibrinogen and an agent which causes the formation of fibrin from fibrinogen to at least one surface of the tissue equivalent of step (b).
Claim 26
Dependent Claim 18 words
The method of claim 21, wherein the agent which causes the formation of fibrin from fibrinogen comprises thrombin.
Claim 27
Dependent Claim 26 words
The method of claim 21, wherein the mixture further comprises an agent or is exposed to an agent which causes the cross-linking of fibrin and collagen.
Claim 28
Dependent Claim 12 words
The method of claim 23, wherein the cross-linking agent comprises Factor XIII.
Claim 29
Dependent Claim 16 words
The method of claim 21, additionally including adding living cells into or onto the tissue equivalent.
Claim 30
Dependent Claim 24 words
The method of claim 21, wherein the collagen and the fibrinogen are each at a concentration of from about 0.3 to about 3.0 mg/ml.
Claim 31
Dependent Claim 35 words
The method of claim 21, wherein the collagen is at a concentration of from about 1.0 to about 1.5 mg/ml and the fibrinogen is at a concentration of from about 1.5 to about 2.5 mg/ml.
Claim 32
Dependent Claim 11 words
A tissue equivalent formed according to the method of claim 21.
Claim 33
Dependent Claim 27 words
The tissue equivalent of claim 28, wherein the collagen and the fibrin are each at a concentration of from about 3.0 to about 30.0 mg/cm 3 .
Claim 34
Dependent Claim 39 words
The tissue equivalent of claim 28, wherein the collagen is at a concentration of from about 10.0 to about 15.0 mg/cm 3 and the fibrin is at a concentration of from about 15.0 to about 25.0 mg/cm 3 .
Claim 35
Independent Claim 108 words
A method of producing a tissue equivalent having at least two layers, the method comprising: (a) forming a mixture comprising collagen and at least one contractile agent under conditions to form a gel having the collagen and contractile agent dispersed within the gel and maintaining the gel under conditions which permit contraction of the gel to form a first tissue equivalent; (b) applying a mixture comprising fibrinogen and thrombin to the first tissue equivalent; and (c) contacting a second tissue equivalent produced in accordance with step (a) above with the first tissue equivalent; and (d) repeating steps (b) and (c) if additional layers of tissue equivalents are desired.
Claim 36
Independent Claim 108 words
A method of producing a tissue equivalent having at least two layers, the method comprising: (a) forming a mixture comprising collagen and at least one contractile agent under conditions to form a gel having the collagen and contractile agent dispersed within the gel and maintaining the gel under conditions which permit contraction of the gel to form a first tissue equivalent; (b) applying a mixture comprising fibrinogen and thrombin to the first tissue equivalent; and (c) contacting a second tissue equivalent produced in accordance with step (a) above with the first tissue equivalent; and (d) repeating steps (b) and (c) if additional layers of tissue equivalents are desired.
Claim 37
Dependent Claim 23 words
The method of claim 31, wherein the mixture of step (a), step (c) or steps (a) and (c) further comprises fibrinogen and thrombin.
Claim 38
Dependent Claim 26 words
A method in accordance with claim 31, wherein a mixture comprising fibrinogen and thrombin is applied to the surface of the tissue equivalent of step (c).
Claim 39
Independent Claim 139 words
A method of producing a tissue equivalent having at least two layers, the method comprising: (a) forming a mixture comprising collagen, at least one contractile agent, fibrinogen and an agent which causes the formation of fibrin from fibrinogen under conditions to form a gel having the collagen, contractile agent, fibrinogen and the agent which causes the formation of fibrin from fibrinogen dispersed within the gel and maintaining the gel under conditions which permit contraction of the gel to form a first tissue equivalent; (b) applying a mixture comprising fibrinogen and an agent which causes the formation of fibrin from fibrinogen to the first tissue equivalent; and (c) contacting a second tissue equivalent produced in accordance with step (a) above with the first tissue equivalent; and (d) repeating steps (b) and (c) if additional layers of tissue equivalents are desired.
Claim 40
Independent Claim 139 words
A method of producing a tissue equivalent having at least two layers, the method comprising: (a) forming a mixture comprising collagen, at least one contractile agent, fibrinogen and an agent which causes the formation of fibrin from fibrinogen under conditions to form a gel having the collagen, contractile agent, fibrinogen and the agent which causes the formation of fibrin from fibrinogen dispersed within the gel and maintaining the gel under conditions which permit contraction of the gel to form a first tissue equivalent; (b) applying a mixture comprising fibrinogen and an agent which causes the formation of fibrin from fibrinogen to the first tissue equivalent; and (c) contacting a second tissue equivalent produced in accordance with step (a) above with the first tissue equivalent; and (d) repeating steps (b) and (c) if additional layers of tissue equivalents are desired.
Claim 41
Independent Claim 132 words
A method of preparing a tissue-equivalent, comprising: (a) forming a acidic solution of collagen; (b) combining fibrinogen, an agent which causes the formation of fibrin from fibrinogen, at least one contractile agent and nutrient medium with the acidic solution of collagen; (c) raising the pH and the temperature of the solution of collagen to a level sufficient to cause the collagen to gel and form a hydrated collagen lattice containing the fibrinogen, the agent which causes the formation of fibrin from fibrinogen, and the contractile agent; and (d) maintaining the lattice, fibrinogen, the agent which causes the formation of fibrin from fibrinogen, and the contractile agent under conditions sufficient for the agent to cleave fibrinogen to form fibrin and the contractile agent to contract the collagen lattice thereby forming a tissue equivalent.
Claim 42
Independent Claim 132 words
A method of preparing a tissue-equivalent, comprising: (a) forming a acidic solution of collagen; (b) combining fibrinogen, an agent which causes the formation of fibrin from fibrinogen, at least one contractile agent and nutrient medium with the acidic solution of collagen; (c) raising the pH and the temperature of the solution of collagen to a level sufficient to cause the collagen to gel and form a hydrated collagen lattice containing the fibrinogen, the agent which causes the formation of fibrin from fibrinogen, and the contractile agent; and (d) maintaining the lattice, fibrinogen, the agent which causes the formation of fibrin from fibrinogen, and the contractile agent under conditions sufficient for the agent to cleave fibrinogen to form fibrin and the contractile agent to contract the collagen lattice thereby forming a tissue equivalent.
Claim 43
Dependent Claim 13 words
The method of claim 35 wherein steps (b) and (c) are done simultaneously.
Claim 44
Dependent Claim 20 words
The method of claim 35, wherein the mixture further comprises an agent which causes the cross-linking of fibrinogen and collagen.
Claim 45
Dependent Claim 11 words
The method of claim 36, wherein the agent is Factor XIII.
Claim 46
Dependent Claim 16 words
The method of claim 35, additionally including adding living cells into or onto the tissue equivalent.
Claim 47
Dependent Claim 24 words
The method of claim 35 wherein the collagen and the fibrinogen are each at a concentration of from about 0.3 to about 3.0 mg/ml.
Claim 48
Dependent Claim 35 words
The method of claim 35, wherein the collagen is at a concentration of from about 1.0 to about 1.5 mg/ml and the fibrinogen is at a concentration of from about 1.5 to about 2.5 mg/ml.
Claim 49
Dependent Claim 10 words
A tissue equivalent formed by the method of claim 35.
Claim 50
Dependent Claim 27 words
The tissue equivalent of claim 42, wherein the collagen and the fibrin are each at a concentration of from about 3 to about 30 mg/cm 3 .
Claim 51
Dependent Claim 39 words
The tissue equivalent of claim 42, wherein the collagen is at a concentration of from about 10 to about 15 mg/cm 3 and the fibrin is at a concentration of from about 15 to about 25 mg/cm 3 .
Claim 52
Dependent Claim 52 words
A method of joining a tear in the tissue equivalent of claim 1, the method comprising: (a) applying a mixture comprising fibrinogen and an agent which causes the formation of fibrin from fibrinogen to the tear; and (b) maintaining the tissue equivalent of step (a) under conditions to permit formation of fibrin.
Claim 53
Independent Claim 77 words
A method of repairing a defect in a tissue equivalent comprising a hydrated collagen lattice contracted by a contractile agent or (i) a hydrated collagen lattice contracted by a contractile agent and (ii) fibrin, the method comprising: (a) applying a mixture comprising fibrinogen and an agent which causes the formation of fibrin from fibrinogen to the defect in the tissue equivalent; and (b) maintaining the tissue equivalent of step (a) under conditions to permit formation of fibrin.
Claim 54
Independent Claim 77 words
A method of repairing a defect in a tissue equivalent comprising a hydrated collagen lattice contracted by a contractile agent or (i) a hydrated collagen lattice contracted by a contractile agent and (ii) fibrin, the method comprising: (a) applying a mixture comprising fibrinogen and an agent which causes the formation of fibrin from fibrinogen to the defect in the tissue equivalent; and (b) maintaining the tissue equivalent of step (a) under conditions to permit formation of fibrin.

References Cited (Backward Citations)

US2533004A Cited
US4298598A Cited
US4377572A Cited
US4414976A Cited
US4427650A Cited
GB2102811A Cited
US4485096A Cited
US4600574A Cited
US4627879A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-06-05 1992-12-05 1993-06-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-06-05 1996-12-05 1997-06-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-06-05 2000-12-05 2001-06-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag